A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer
Condition: Breast Cancer Intervention: Drug: AC682 Sponsor: Accutar Biotechnology Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials